Mobix Labs insider plans sale of 25,000 shares

A Form 144 notice for Mobix Labs reports that Philip Sansone plans to sell 25,000 shares of common stock.

Rhea-AI Filing Summary

A Form 144 notice for Mobix Labs reports that Philip Sansone plans to sell 25,000 shares of common stock. These shares are scheduled to be acquired through RSU vesting on 07/16/2026 and may be sold beginning 07/17/2026 through J.P. Morgan Securities LLC on NASDAQ.

The notice also lists a prior sale of common stock on 05/01/2026 involving 9,541 shares within the past three months.

Key Figures

Planned sale quantity: 25000 shares RSU vesting date: 07/16/2026 Earliest sale date: 07/17/2026 +2 more

5 metrics

Planned sale quantity 25000 shares Common stock to be sold under Form 144

RSU vesting date 07/16/2026 Acquisition date for shares to be sold

Earliest sale date 07/17/2026 Planned sale date for RSU-related shares

Prior sale quantity 9541 shares Common stock sold within past three months on 05/01/2026

Reported figure for prior sale 22463.58 Amount reported with 05/01/2026 past three-months transaction

Key Terms

Form 144, RSU Vesting, equity compensation, Securities To Be Sold

4 terms

Form 144 regulatory

"A Form 144 notice for Mobix Labs reports that Philip Sansone plans to sell"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vesting financial

"These shares are scheduled to be acquired through RSU vesting on 07/16/2026"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

equity compensation financial

"Mobix Labs (issuer) | | | 25000 | 07/17/2026 | equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 07/16/2026 | RSU Vesting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What planned share sale does the Form 144 for MOBX disclose?

The Form 144 indicates that Philip Sansone plans to sell 25,000 Mobix Labs common shares. These shares are tied to RSU vesting on 07/16/2026 and are expected to be eligible for sale starting 07/17/2026.

How were the 25,000 Mobix Labs (MOBX) shares acquired?

The 25,000 Mobix Labs shares are to be acquired through RSU vesting dated 07/16/2026. The Form 144 describes the nature of this acquisition as equity compensation from Mobix Labs as the issuer.

When can the reported Mobix Labs (MOBX) shares be sold under this Form 144?

The shares are reported as eligible for sale beginning 07/17/2026. The Form 144 links this sale date to RSU vesting that occurs on 07/16/2026, with trades expected to be executed through J.P. Morgan Securities LLC.

Which broker is listed for the planned Mobix Labs (MOBX) Form 144 sale?

The planned sale of Mobix Labs common stock is listed through J.P. Morgan Securities LLC. The broker is identified with its New York address and NASDAQ is noted as the market where the common stock is traded.

What recent Mobix Labs (MOBX) stock sales are disclosed for the past 3 months?

The notice records a prior sale of Mobix Labs common stock on 05/01/2026 involving 9,541 shares. An additional figure of 22463.58 is reported in connection with this transaction in the past three-months section.

Who is the reporting person in the Mobix Labs (MOBX) Form 144?

The Form 144 lists Philip Sansone with an address in Irvine, California as the person associated with the transactions. His name appears both for the planned sale and the common stock already sold within the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 12:38 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002067346
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mobix Labs, Inc.
SEC File Number	001-40621
Address of Issuer	1 Venture Suite 220 Irvine CALIFORNIA 92618
Phone	949-808-8888
Name of Person for Whose Account the Securities are To Be Sold	Philip Sansone
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	9301	17364.39	14998187	07/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/16/2026	RSU Vesting	Mobix Labs (issuer)			25000	07/17/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Philip Sansone 1 Venture Irvine CA 92618	Common Stock	05/01/2026	9541	22463.58

144: Remarks and Signature

Remarks
Date of Notice	07/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Philip Sansone, Mobix Labs, Inc.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)